[25-013787] nhlbi cellular and molecular therapeutics laboratory requires the phage library in order to perform upcoming experiments in genetic analysis. Our laboratory is focused on developing…
Ended Purchase Order Awarded Last action
- Contract number
- 75N92025P00347
- Awardee
-
Proteogenix UEI CP2GCU4XTVM7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,440
Award facts
- Contract value 100% obligated
- $15,440.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- France
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $15,440 firm fixed-price purchase order to Proteogenix, a biotechnology manufacturer based in Schiltigheim, France, on August 28, 2025. The contract, which utilizes no set-aside designation, requires delivery of a phage library to support the NHLBI's Cellular and Molecular Therapeutics Laboratory in conducting genetic analysis experiments. The phage library will facilitate the laboratory's ongoing research into hematopoietic stem cell (HSC) therapy with gene modification capabilities, with work to be completed by November 1, 2025.
This award represents part of Proteogenix's established relationship with NHLBI, where the vendor has demonstrated specialized expertise in advanced laboratory screening and research support services for gene therapy development. The company's prior contract work with NHLBI has included phage-display library screening and VHH antibody screening services, positioning it to deliver the sophisticated biotechnological products and support required for this HSC therapy research initiative. As a registered SAM.gov vendor in good standing, Proteogenix continues to support NHLBI's Center for Molecular Therapeutics and Bioanalytics in advancing innovative therapeutic approaches through targeted genetic research methodologies.
Description
[25-013787] nhlbi cellular and molecular therapeutics laboratory requires the phage library in order to perform upcoming experiments in genetic analysis. Our laboratory is focused on developing hematopoietic stem cell (HSC) therapy with gene modifica
Quick answers
Who was awarded contract 75N92025P00347?
75N92025P00347 was awarded to Proteogenix by National Heart Lung and Blood Institute (National Institutes of Health) on August 28, 2025.
How much is contract 75N92025P00347 worth?
The government has obligated $15,440 on 75N92025P00347.
Was contract 75N92025P00347 competed?
The extent of competition for 75N92025P00347 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award